
Arthroplasty
TKA prophylaxis: Risk-dependent anticoagulation safer than routine anticoagulation
J Arthroplasty. 2013 Dec;28(10):1868-73. doi: 10.1016/j.arth.2013.05.025. Epub 2013 Jun 21.673 patients undergoing primary or a staged bilateral total knee arthroplasty (900 procedures) were randomized to receive thromboprophylactic treatment either based on their level of risk for deep venous thrombosis (DVT), or according to a routine anticoagulation protocol. The purpose of this study was to compare these two protocols on the resulting incidence of deep vein thrombosis and wound complications. Results after 1 year indicated that the risk stratification group had a similar incidence of DVT and a significantly lower incidence of wound complications, when compared to the routine anticoagulation group.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.